1.
Cutis
; 73(1): 81-5, 2004 Jan.
Article
in English
| MEDLINE
| ID: mdl-14964637
ABSTRACT
Dermatologists and other physicians frequently encounter simple chronic paronychia and onycholysis. In addition to strict avoidance of contact irritants, a broad-spectrum topical antifungal agent has been recommended. We conducted an examination of treatment with this type of agent and an assessment of the efficacy of ciclopirox 0.77% topical suspension in combination with a strict irritant-avoidance regimen. Early results of a pilot study (N = 44) using ciclopirox 0.77% topical suspension in patients diagnosed with simple chronic paronychia and/or onycholysis show excellent therapeutic outcomes of a combined regimen of a broad-spectrum topical antifungal agent such as ciclopirox and contact-irritant avoidance in this patient population.
Subject(s)
Antifungal Agents/therapeutic use , Onychomycosis/drug therapy , Paronychia/drug therapy , Pyridones/therapeutic use , Administration, Topical , Adolescent , Adult , Aged , Aged, 80 and over , Chronic Disease , Ciclopirox , Dose-Response Relationship, Drug , Drug Administration Schedule , Female , Follow-Up Studies , Humans , Male , Middle Aged , Onychomycosis/diagnosis , Paronychia/diagnosis , Prospective Studies , Sampling Studies , Severity of Illness Index , Treatment Outcome
2.
J Drugs Dermatol
; 2(1): 50-1, 2003 Jan.
Article
in English
| MEDLINE
| ID: mdl-12852382